These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4524459)

  • 1. [Electron microscopic bone marrow changes in acute leukemias before and after cytosin-arabinoside therapy].
    Ruzicka F; Weigerstorfer B
    Verh Dtsch Ges Inn Med; 1973; 79():369-72. PubMed ID: 4524459
    [No Abstract]   [Full Text] [Related]  

  • 2. An extreme example of focal bone marrow involvement in acute myeloid leukemia.
    Brierley CK; Morgan EA; Sprague JR; Odejide OO; DeAngelo DJ; Steensma DP
    Am J Hematol; 2013 Apr; 88(4):335-6. PubMed ID: 23115117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basophilic acute leukemias (author's transl)].
    Quattrin N
    Nouv Rev Fr Hematol; 1973; 13(6):745-54. PubMed ID: 4280040
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with daunomycin and cytosine arabinoside in the therapy of acute myeloid leukemias].
    Kreiter H; Begemann H; Rastetter J
    Med Klin; 1968 Dec; 63(51):2058-66. PubMed ID: 5255517
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of recent studies of cellular proliferation in acute leukemia.
    Clarkson BD
    Natl Cancer Inst Monogr; 1969 May; 30():81-120. PubMed ID: 5260445
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
    Peters WG; Willemze R; Colly LP; Colla L
    Br J Haematol; 1985 Apr; 59(4):733-4. PubMed ID: 3857074
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytosine-arabinoside in the treatment of acute myeloblastic leukemias].
    Maroncelli P; Canova R; Casalino C; Fischioni P
    Minerva Med; 1971 Mar; 62(21):1110-9. PubMed ID: 5279670
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evolution and therapy of blastic crises].
    Tura S; Baccarani M; Zaccaria A
    Minerva Med; 1975 Jul; 66(51):2553-60. PubMed ID: 1057051
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute leukemias in the infancy with cytosine arabinoside].
    Madon E; Baroncelli PG; Sacerdote A; Roberi PL
    Minerva Pediatr; 1971 Jun; 23(26):1125-9. PubMed ID: 5286310
    [No Abstract]   [Full Text] [Related]  

  • 12. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
    Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
    Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute promyelocytic leukemia. A childhood cluster.
    Gilbert RD; Karabus CD; Mills AE
    Cancer; 1987 Mar; 59(5):933-5. PubMed ID: 3469010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results in the treatment of acute granulocytic leukemias using a combination of daunorubicine-cytosine arabinoside-cyclophosphamide. Apropos of 35 cases].
    Bauters F; Plouvier B; Caulier MT; Mouton J; Goudemand M
    Lille Med; 1974 Mar; 19(3):226-31. PubMed ID: 4612276
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of a new relapse treatment for acute myeloid leukemia (AML) on in vitro granulopoiesis.
    Müller MR; Sauter C; Erni J; Martz G
    Anticancer Res; 1983; 3(2):127-31. PubMed ID: 6573868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
    Dick FR; Burns CP; Weiner GJ; Heckman KD
    Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose cytarabine therapy in hypoplastic acute leukemia.
    Manoharan A
    N Engl J Med; 1983 Dec; 309(26):1652-3. PubMed ID: 6580525
    [No Abstract]   [Full Text] [Related]  

  • 19. [Abnormalities of the erythropoiesis at the beginning of remission in acute promyelocytic leukemia treated with arabinoside-cytosine].
    Dubois-Ferrière H; Aguercif M; Hazeghi P; Rudhardt M
    Schweiz Med Wochenschr; 1970 Feb; 100(7):321-3. PubMed ID: 5263342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of acute myeloid leukemias and lymphoproliferative syndromes by electron microscopy].
    Laporte EM; de Almeida TV
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):241-52. PubMed ID: 2843981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.